According to Catalent's latest financial reports and stock price the company's current number of shares outstanding is 182,000,000. At the end of 2023 the company had 182,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.18 B | 0.55% |
2022 | 0.18 B | 3.15% |
2021 | 0.17 B | 5.07% |
2020 | 0.16 B | 14.33% |
2019 | 0.14 B | 0.7% |
2018 | 0.14 B | 9.08% |
2017 | 0.13 B | 6.48% |
2016 | 0.12 B | 0.06% |
2015 | 0.12 B | -0.68% |
2014 | 0.12 B | 7.12% |
2013 | 0.11 B | 0% |
2012 | 0.11 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Supernus Pharmaceuticals
SUPN | 54,608,963 | -70.00% | ๐บ๐ธ USA |
Jazz Pharmaceuticals JAZZ | 62,537,000 | -65.64% | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | 47,819,936 | -73.73% | ๐บ๐ธ USA |
Intercept Pharmaceuticals
ICPT | 41,792,000 | -77.04% | ๐บ๐ธ USA |